These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 23243267)

  • 21. Autoantibodies in haemolytic uraemic syndrome (HUS).
    Skerka C; Józsi M; Zipfel PF; Dragon-Durey MA; Fremeaux-Bacchi V
    Thromb Haemost; 2009 Feb; 101(2):227-32. PubMed ID: 19190803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atypical hemolytic uremic syndrome: Korean pediatric series.
    Lee JM; Park YS; Lee JH; Park SJ; Shin JI; Park YH; Yoo KH; Cho MH; Kim SY; Kim SH; Namgoong MK; Lee SJ; Lee JH; Cho HY; Han KH; Kang HG; Ha IS; Bae JS; Kim NK; Park WY; Cheong HI
    Pediatr Int; 2015 Jun; 57(3):431-8. PubMed ID: 25443527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association among Complement Factor H Autoantibodies, Deletions of CFHR, and the Risk of Atypical Hemolytic Uremic Syndrome.
    Jiang H; Fan MN; Yang M; Lu C; Zhang M; Liu XH; Ma L
    Int J Environ Res Public Health; 2016 Dec; 13(12):. PubMed ID: 27929404
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Piras R; Valoti E; Alberti M; Bresin E; Mele C; Breno M; Liguori L; Donadelli R; Rigoldi M; Benigni A; Remuzzi G; Noris M
    Front Immunol; 2022; 13():1011580. PubMed ID: 36793547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CFH-CFHR1 hybrid genes in two cases of atypical hemolytic uremic syndrome.
    Sugawara Y; Kato H; Nagasaki M; Yoshida Y; Fujisawa M; Minegishi N; Yamamoto M; Nangaku M
    J Hum Genet; 2023 Jun; 68(6):427-430. PubMed ID: 36755127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factor H autoantibodies and deletion of Complement Factor H-Related protein-1 in rheumatic diseases in comparison to atypical hemolytic uremic syndrome.
    Foltyn Zadura A; Zipfel PF; Bokarewa MI; Sturfelt G; Jönsen A; Nilsson SC; Hillarp A; Saxne T; Trouw LA; Blom AM
    Arthritis Res Ther; 2012 Aug; 14(4):R185. PubMed ID: 22894814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The autoimmune disease DEAP-hemolytic uremic syndrome.
    Skerka C; Zipfel PF; Müller D; Micklisch S; Riedl M; Zimmerhackl LB; Hofer J
    Semin Thromb Hemost; 2010 Sep; 36(6):625-32. PubMed ID: 20865639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children.
    Sinha A; Gulati A; Saini S; Blanc C; Gupta A; Gurjar BS; Saini H; Kotresh ST; Ali U; Bhatia D; Ohri A; Kumar M; Agarwal I; Gulati S; Anand K; Vijayakumar M; Sinha R; Sethi S; Salmona M; George A; Bal V; Singh G; Dinda AK; Hari P; Rath S; Dragon-Durey MA; Bagga A;
    Kidney Int; 2014 May; 85(5):1151-60. PubMed ID: 24088957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An unusual case of adult-onset still's disease complicated with anti-complement factor H antibodies associated atypical haemolytic uraemic syndrome.
    Fung WW; Chao AC; Pang WF; Wong RS; Chow KM; Szeto CC
    BMC Nephrol; 2024 May; 25(1):164. PubMed ID: 38745129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal transplantation under prophylactic eculizumab in atypical hemolytic uremic syndrome with CFH/CFHR1 hybrid protein.
    Krid S; Roumenina LT; Beury D; Charbit M; Boyer O; Frémeaux-Bacchi V; Niaudet P
    Am J Transplant; 2012 Jul; 12(7):1938-44. PubMed ID: 22494769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High Complement Factor H-Related (FHR)-3 Levels Are Associated With the Atypical Hemolytic-Uremic Syndrome-Risk Allele
    Pouw RB; Gómez Delgado I; López Lera A; Rodríguez de Córdoba S; Wouters D; Kuijpers TW; Sánchez-Corral P
    Front Immunol; 2018; 9():848. PubMed ID: 29740447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Copy number variation analysis using next-generation sequencing identifies the
    Park J; Yhim HY; Kang KP; Bae TW; Cho YG
    Hematology; 2022 Dec; 27(1):603-608. PubMed ID: 35617302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel hybrid CFH/CFHR3 gene generated by a microhomology-mediated deletion in familial atypical hemolytic uremic syndrome.
    Francis NJ; McNicholas B; Awan A; Waldron M; Reddan D; Sadlier D; Kavanagh D; Strain L; Marchbank KJ; Harris CL; Goodship TH
    Blood; 2012 Jan; 119(2):591-601. PubMed ID: 22058112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factor H Competitor Generated by Gene Conversion Events Associates with Atypical Hemolytic Uremic Syndrome.
    Goicoechea de Jorge E; Tortajada A; García SP; Gastoldi S; Merinero HM; García-Fernández J; Arjona E; Cao M; Remuzzi G; Noris M; Rodríguez de Córdoba S
    J Am Soc Nephrol; 2018 Jan; 29(1):240-249. PubMed ID: 28993505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of genetic and predisposing factors in Japanese patients with atypical hemolytic uremic syndrome.
    Fan X; Yoshida Y; Honda S; Matsumoto M; Sawada Y; Hattori M; Hisanaga S; Hiwa R; Nakamura F; Tomomori M; Miyagawa S; Fujimaru R; Yamada H; Sawai T; Ikeda Y; Iwata N; Uemura O; Matsukuma E; Aizawa Y; Harada H; Wada H; Ishikawa E; Ashida A; Nangaku M; Miyata T; Fujimura Y
    Mol Immunol; 2013 Jun; 54(2):238-46. PubMed ID: 23314101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atypical hemolytic uremic syndrome in children: complement mutations and clinical characteristics.
    Geerdink LM; Westra D; van Wijk JA; Dorresteijn EM; Lilien MR; Davin JC; Kömhoff M; Van Hoeck K; van der Vlugt A; van den Heuvel LP; van de Kar NC
    Pediatr Nephrol; 2012 Aug; 27(8):1283-91. PubMed ID: 22410797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factor H and CFHR1 polymorphisms associated with atypical Haemolytic Uraemic Syndrome (aHUS) are differently expressed in Tunisian and in Caucasian populations.
    Leban N; Abarrategui-Garrido C; Fariza-Requejo E; Amiñoso-Carbonero C; Pinto S; Chibani JB; Khelil AH; Sánchez-Corral P
    Int J Immunogenet; 2012 Apr; 39(2):110-3. PubMed ID: 22136554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological features and functional analysis of anti-CFH autoantibodies in patients with atypical hemolytic uremic syndrome.
    Guo WY; Song D; Liu XR; Chen Z; Xiao HJ; Ding J; Sun SZ; Liu HY; Wang SX; Yu F; Zhao MH;
    Pediatr Nephrol; 2019 Feb; 34(2):269-281. PubMed ID: 30315407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
    Frémeaux-Bacchi V; Fakhouri F; Roumenina L; Dragon-Durey MA; Loirat C
    Rev Med Interne; 2011 Apr; 32(4):232-40. PubMed ID: 21376430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful treatment of DEAP-HUS with eculizumab.
    Noone D; Waters A; Pluthero FG; Geary DF; Kirschfink M; Zipfel PF; Licht C
    Pediatr Nephrol; 2014 May; 29(5):841-51. PubMed ID: 24249282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.